Metheptazine
Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s.[1]
 | |
 | |
| Clinical data | |
|---|---|
| Other names | Metheptazine |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
- US Patent 2740777 PROCESS FOR THE PREPARATION OF HEXAHYDRO-1,3-DIMETHYL- 4-PHENYLAZEPINE-4-CARBOXYLIC ACID, ETHYL ESTER
- http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.